A Randomized Clinical Trial of Linagliptin vs. Standard of Care in Patients Hospitalized With Diabetes and COVID-19

OBJECTIVE: To assess the effect of linagliptin vs. standard therapy in improving clinical outcomes in patients hospitalized with diabetes and coronavirus disease 2019 (COVID-19). MATERIALS AND METHODS: We did an open-label, prospective, multicenter, randomized clinical trial in 3 Israeli hospitals b...

Descripción completa

Detalles Bibliográficos
Autores principales: Abuhasira, Ran, Ayalon-Dangur, Irit, Zaslavsky, Neta, Koren, Ronit, Keller, Mally, Dicker, Dror, Grossman, Alon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727772/
https://www.ncbi.nlm.nih.gov/pubmed/35002970
http://dx.doi.org/10.3389/fendo.2021.794382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727772/
https://www.ncbi.nlm.nih.gov/pubmed/35002970
http://dx.doi.org/10.3389/fendo.2021.794382

Ejemplares similares